Large-scale testing (Phase 3)Study completedNCT04750226
What this trial is testing
Study To Assess Adverse Events and Change in Disease Activity Of 24-hour Continuous Subcutaneous Infusion Of ABBV-951 In Adult Participants With Advanced Parkinson's Disease
Who this might be right for
Parkinson's Disease (PD)
AbbVie 118